title: Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?
authors.affiliation: Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands Department of Surgery, Maastricht University Medical Center, Maastricht, The Netherlands GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.
authors.forename: Guusje
authors.initials: G
authors.lastname: Vugts
authors.forename: Grard A P
authors.initials: GA
authors.lastname: Nieuwenhuijzen
authors.forename: Adriana J G
authors.initials: AJ
authors.lastname: Maaskant-Braat
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Schipper
authors.forename: Marjolein L
authors.initials: ML
authors.lastname: Smidt
mesh_terms: D000230:Adenocarcinoma / Q000000981:diagnostic imaging*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals
chemical_list: D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals